I think you're right.
The business is neither fish nor fowl in the eyes of the market.
I think that the intention to acquire using appropriately priced scrip has been scuppered so the business is now only half pregnant, and the board's hands are bit tied as a result.
In my view, on the Predator <->Prey continuum, SEQ has gone from Predator=90% / Prey=10% a year ago, to Predator=30% / Prey=70% today.
A private equity outfit could pay 40% above market value for the company, strip out the cash, sell most of the bits to specialist industry incumbents, mildly gear whatever gets retained as the rump, a be free carried with some change to spare.
I mean, Morrisons' $6.5m EBITDA alone could justify the current ~$50m Enterprise Value.
If something internal doesn't happen soon - say the next 6 to 9 months - to take the market value of the company closer to its fair value, the stock will increasingly become the sitting duck it already is.
I wonder how long will it take, if at all, for the Board to form a view that the above path - i.e., hanging a For Sale shingle outside the company door - is the most optimal path to extracting shareholder value.
Of course, there is a risk that they use the balance sheet firepower to make acquisitions as part of a takeover defence strategy.
Which I doubt will be at all a good thing.
.
- Forums
- ASX - By Stock
- SEQ
- Ann: Business Update 2022 AGM
SEQ
sequoia financial group ltd
Add to My Watchlist
1.43%
!
35.5¢

Ann: Business Update 2022 AGM, page-26
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
35.5¢ |
Change
0.005(1.43%) |
Mkt cap ! $43.87M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 35.0¢ | $37.20K | 105.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 56039 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 19052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 56039 | 0.350 |
1 | 2944 | 0.340 |
2 | 2992 | 0.335 |
2 | 13000 | 0.330 |
1 | 1550 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 19052 | 2 |
0.360 | 134902 | 2 |
0.365 | 72540 | 3 |
0.370 | 33513 | 2 |
0.375 | 89000 | 3 |
Last trade - 15.00pm 27/06/2025 (20 minute delay) ? |
Featured News
SEQ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online